SNDX stock forecast
Our latest prediction for Syndax Pharmaceuticals, Inc.'s stock price was made on the Oct. 10, 2019 when the stock price was at 5.80$.
In the short term (2weeks), SNDX's stock price should outperform the market by 5.01%. During that period the price should oscillate between -8.74% and +16.78%.
In the medium term (3months), SNDX's stock price should outperform the market by 2.46%. During that period the price should oscillate between -21.22% and +38.72%.Get email alerts
Create a solid portfolio with SNDX
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in Waltham, MA.
At the moment the company generates 2M USD in revenues.
On its last earning announcement, the company reported a loss of -2.38$ per share.
The book value per share is 2.04$
Three months stock forecastOct. 10, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|